Owlstone Medical partners with Shanghai Renji Hospital
China | News | 0 Comment | 22 Feb, 2019
Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji Hospital has announced a collaboration to con...Read more
HaiHe Biopharma, CSPC form a JV to co-develop innovative drugs
China | News | 0 Comment | 22 Feb, 2019
Shanghai based HaiHe Biopharma , which focuses on the discovery, development and commercialization of innovative drugs for cancer, and China's famous pharmaceutical group, China Shijiazhuan...Read more
HLT, PPD collaborate to enhance drug development
China | News | 0 Comment | 21 Feb, 2019
Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (HLT) of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development ...Read more
Medical Insurance for basic services at SCMCC
China | News | 0 Comment | 21 Feb, 2019
Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of a network of radiotherapy and diagnostic imaging centres in China, has a...Read more
YITU Healthcare publishes major AI breakthrough
China | News | 0 Comment | 20 Feb, 2019
YITU Healthcare has successfully used natural language processing (NLP) to achieve high accuracy rates on par with doctors when reading electronic health records and generating patient diag...Read more
WuXi STA signs exclusive technology and marketing partnership with BioLingus
China | News | 0 Comment | 19 Feb, 2019
STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus, a Swiss biotech company, have formed an exclusive technology and marketing collaboration for ...Read more
EMA completes inspection of cGMP DS and DP facilities at WuXi Biologics
China | News | 0 Comment | 19 Feb, 2019
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that the E...Read more
Chipscreen Biosciences unites with Innovent for colorectal cancer therapy
China | News | 0 Comment | 18 Feb, 2019
Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel small molecule pharmaceuticals with a primary focus in oncology, metab...Read more
Cigna brings Medical Plan on OneDegree Global's Online Platform
China | News | 0 Comment | 18 Feb, 2019
Cigna Corporation's Hong Kong business has announced that its Cigna Plus Medical Plan health insurance product is now available on the new digital platform powered by On...Read more
Burning Rock completes Series C financing of RMB 850M
China | News | 0 Comment | 15 Feb, 2019
Burning Rock recently held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB Int...Read more
Innovent announces first patient dosing of IBI 101 study
China | News | 0 Comment | 15 Feb, 2019
Innovent Biologics, Inc. (Innovent) , a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology,...Read more
Ascletis, 3-V Biosciences ink strategic license agreement for NASH drug
China | News | 0 Comment | 14 Feb, 2019
Ascletis Pharma through its subsidiary, and 3-V Biosciences have entered into an exclusive license agreement for 3-V Biosciences' FASN (fatty acid synthase) inhibitor TVB-2640 (Ascletis cod...Read more
3SBio and Verseau team up for Immuno-Oncology Therapies
China | News | 0 Comment | 13 Feb, 2019
3SBio and Verseau Therapeutics have announced a partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of immuno-oncology for a b...Read more
WuXi Biologics enters into commercial manufacturing partnership with Amicus
China | News | 0 Comment | 13 Feb, 2019
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeut...Read more
Samsung Bioepis, C-Bridge Capital to develop next-gen biosimilars
China | News | 0 Comment | 12 Feb, 2019
Samsung Bioepis Co., Ltd. has announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from Samsung...Read more
Female contraceptive market set to be worth $8.7bn by 2027
China | News | 0 Comment | 11 Feb, 2019
Contraceptive market sales were estimated to be $6.3bn across the 8MM (US, France, Germany, Italy, Spain, UK, Japan and China) in 2017, which is expected to grow to $8.2bn in 2027, at ...Read more
Lunar New Year focuses on traditional chinese medicine for cancer treatment
China | Opinion | 0 Comment | 09 Feb, 2019
The Lunar New Year welcomes a focus on the wellbeing of the entire body leading to renewed discussions about the benefits of traditional Chinese medicine (TCM). The popularity of TC...Read more
CStone, IMPACT Therapeutics’ anti-tumor therapy gets IND filing acceptance
China | News | 0 Comment | 08 Feb, 2019
CStone Pharmaceutical and IMPACT Therapeutics, Inc. have jointly announced that an Investigational New Drug (IND) filing has been accepted by the National Medical Products Administration (N...Read more